Provided by Tiger Fintech (Singapore) Pte. Ltd.

iTeos Therapeutics

10.17
+0.19001.90%
Volume:1.11M
Turnover:11.21M
Market Cap:389.24M
PE:-3.29
High:10.19
Open:10.00
Low:9.96
Close:9.98
Loading ...

CEO Michel Detheux Reports Disposal of Common Shares of iTeos Therapeutics Inc

Reuters
·
12 Jun

Iteos Therapeutics CEO Michel Detheux Reports Disposal of Common Shares

Reuters
·
07 Jun

Tim Van Hauwermeiren Resigns from iTeos Therapeutics Board of Directors

Reuters
·
06 Jun

iTeos Therapeutics: Strategic Wind Down to Maximize Shareholder Value Amid Limited Pipeline Prospects

TIPRANKS
·
30 May

iTeos Therapeutics downgraded to Equal Weight at Wells Fargo on wind down

TIPRANKS
·
28 May

BRIEF-I Teos Therapeutics Inc Expected Severance Costs Of $21.8 Million To $24.7 Million

Reuters
·
28 May

iTeos Therapeutics Cut to Neutral From Outperform by Wedbush

Dow Jones
·
28 May

Wedbush Downgrades iTeos Therapeutics to Neutral From Outperform, Adjusts Price Target to $12 From $10

MT Newswires Live
·
28 May

iTeos Therapeutics downgraded to Neutral at Wedbush after wind down decision

TIPRANKS
·
28 May

Iteos Therapeutics Inc : Wedbush Cuts to Neutral From Outperform; Raises Target Price to $12 From $10

THOMSON REUTERS
·
28 May

Iteos Therapeutics Shares Jump 31%; Co Plans to Wind Down Operations, Explores Potential Asset Sales

THOMSON REUTERS
·
28 May

BUZZ-ITeos rises on plans to explore asset sales, use cash reserves

Reuters
·
28 May

Iteos Therapeutics Inc - Expected Severance Costs of $21.8 Mln to $24.7 Mln - SEC Filing

THOMSON REUTERS
·
28 May

iTeos plans to shut down operations after cancer therapy setback

Reuters
·
28 May

Iteos Therapeutics Shares Jump 20% Premarket; Co Plans to Wind Down Operations, Explores Potential Asset Sales

THOMSON REUTERS
·
28 May

Iteos Therapeutics Inc - Exploring Potential Asset Sales Including Eos-984 and Eos-215

THOMSON REUTERS
·
28 May

Iteos Therapeutics Inc - Board Intends to Cease Operations

THOMSON REUTERS
·
28 May

Iteos Therapeutics Announces Its Intention to Wind Down Operations

THOMSON REUTERS
·
28 May

iTeos Therapeutics Announces Plan to Wind Down Operations and Explore Asset Sales to Maximize Shareholder Value

Reuters
·
28 May

Major Shareholder Makes Bold Move with iTeos Therapeutics Stock

TIPRANKS
·
17 May